Cell-cycle control is another major aspect of melanoma regulation, the cyclin-dependent kinase inhibitor CDKN2A encodes P16 and P14ARF proteins, both of which can be mutated, deleted, or silenced in melanoma. Here, CDKN2A is linked to melanoma.